Skip to content Skip to footer
Subscribe Now

VIEWPOINTS

VIEWPOINTS_Moitreyee Chatterjee-Kishore_2023
Moitreyee Chatterjee-Kishore, in an absorbing conversation with PharmaShots, shares the highlights of the SPOTLIGHT & GLOW study
Shots:   Moitreyee Chatterjee-Kishore, HOD, Immuno-Oncology & Cancer Cell Therapy at Astellas shares insights from the P-III trials (SPOTLIGHT & GLOW)   In SPOTLIGHT and GLOW, zolbetuximab and chemotherapy demonstrated improved PFS and OS vs placebo plus chemotherapy, yielding positive outcomes for patients with advanced gastric or GEJ cancer.   Moitreyee highlights the ongoing clinical trials for the…
November 29, 2023
VIEWPOINTS_Michael Irizarry_2023
Michael Irizarry shares insights from the P-III clinical study of LEQEMBI, for the treatment of Alzheimer’s disease
Shots: Michael Irizarry, Senior VP of Clinical Research and Deputy Chief Clinical Officer, Alzheimer’s Disease and Brain Health at Eisai in a stimulating conversation with PharmaShots Michael shares insights from the P-III clinical study Clarity AD of LEQEMBI for the treatment of Alzheimer’s disease The study highlights that LEQEMBI treatment met the primary endpoint and…
November 27, 2023
VIEWPOINTS_Matthew G. Fishler_2023
Matthew G. Fishler Shares the Highlights of AVEIR DR, the World’s First Dual-Chamber Leadless Pacemaker System
Shots:  Matthew G. Fishler, Chief Engineer and Director of Product Development Abbott’s Cardiac Rythm Management Business, in an insightful conversation with PharmaShots   Matthew shares the highlights of the recently approved AVEIR Dr, the world’s first dual-chamber leadless pacemaker system for patients with slower-than-normal or abnormal heart rhythms   Equipped with i2i™ communication technology, AVIER DR eliminates…
November 20, 2023
VIEWPOINTS_Jane Reed_2023
Jane Reed Highlights the Growing Dependence of NLP to Comply with the Regulatory Guidelines
Shots:  In an invigorating conversation with PharmaShots, Jane Reed discusses the transition from document-driven to data-driven decision-making in the pharmaceutical industry   Jane sheds light on the increasing dependence on AI and ML in regulatory affairs and how it helps pharma companies mitigate errors, discrepancies, and non-compliance   Jane highlights the benefits of NLP in ensuring regulatory…
November 16, 2023
VIEWPOINTS_Micah Litow_2023
Micah Litow shares insights from the 2023 Kalderos Annual Report on drug discount programs
Shots:  Micah Litow, in a stimulating conversation with PharmaShots, shares insights from the 2023 Kalderos Annual Report on drug discount programs   Micah highlights the challenges the drug manufacturers, covered entities, and state payers face on account of US drug discount programs   Micah sheds light on how Kalderos' MDRP Discount Monitoring solution helps drug manufacturers prevent…
November 9, 2023
VIEWPOINTS_Marisa Cruz_2023
Marisa Cruz, in an insightful conversation with PharmaShots, discusses the Empatica Health Monitoring Platform (EHMP)
Shots:  Marisa Cruz, MD, and Chief Medical Officer at Empatica, exchanged thoughts with PharmaShots on the revolutionary Empatica Health Monitoring Platform (EHMP)   Approved by the FDA in Nov’2022, EHMP leverages a cloud-based online portal to collect continuous and seamless physiological data from home and clinical setting   While conversing in great depth about Empatica’s EmbracePlus smartwatch,…
November 2, 2023
VIEWPOINTS_Liz Hurlburt_2023
Liz Hurlburt sheds light on DefenCath, a one of the kind, catheter lock solution
Shots:  Liz Hurlburt, Executive Vice President of Clinical & Medical Affairs at CorMedix discusses the revolutionary prospects of DefenCath, a catheter lock solution to prevent CRBSIs in patients receiving hemodialysis via. CVC   Liz sheds light on a serious unmet need for patients affected with catheter-related bloodstream infections. CRBSIs affect approximately 250,000 people annually who receive…
October 31, 2023
Load more